A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease

Drug Metabolism and Drug Interactions

Volumn 18, Issue 2, 2001, Pages 79-98

  Steventon, Glyn B ^a   Sturman, Steve ^a   Waring, Rosemary H ^a   Williams, Adrian C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Motor neuron disease; Parkinson's disease; Pharmacogenetics; Xenobiotic metabolising enzymes

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBOCISTEINE; REACTIVE OXYGEN METABOLITE;

CELL DEATH; DOPAMINERGIC TRANSMISSION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENETIC VARIABILITY; GENOMICS; HUMAN; MOTOR NEURON DISEASE; NERVE DEGENERATION; PARKINSON DISEASE; PHARMACOGENETICS; REVIEW; XENOBIOTIC METABOLISM;

EID: 0035746226     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2001.18.2.79     Document Type: Review

References (35)

1. Phenotypic variation in xenobiotic metabolism and adverse environmental response: Focus on sulfur-dependent detoxification pathways
2. Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine
3. Cytochrome P450 and Parkinson disease. Poor parahydroxylation of phenytoin
4. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease
5. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication?
6. Effect of overexpression of the wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: Relevance to Down's syndrome and familiar amyotrophic lateral sclerosis
7. Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease
8. Might environmental factors contribute to neurodegenerative disease?
9. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
10. Pesticide toxicity and motor neurone disease
11. Xenobiotic metabolism in motorneuron disease
12. Xenobiotic metabolism in Parkinson's disease
13. S-Methylation in motorneuron disease and Parkinson's disease
14. Acetaminophen metabolism by cytochrome P450 monooxygenase in Parkinson's disease
15. Metabolism of low-dose paracetamol in patients with chronic neurological disease
16. Xenobiotic metabolism in Alzheimer's disease
17. Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease
18. Metabolism of S-carboxymethyl-L-cysteine in humans: A neurodegenerative disease study
19. Parkinson's disease and CYP1A2 activity
20. Debrisoquine metabolism in Parkinsonian patients treated with antihistamine drugs
21. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man
22. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
23. Mutant debrisoquine hydroxylation genes in Parkinson's disease
24. CYP2D6 phenotyping and neurodegenerative diseases
25. Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease
26. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders
27. Acetaminophen sulfation in patients with Parkinson's disease or Huntington's disease is not impaired
28. Cysteine dioxygenase
29. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals
30. Role of mitochondria in Parkinson's disease
31. 35S-D-penicillamine in man
32. D-Penicillamine induced toxicity in rheumatoid arthritis. The role of sulphoxidation status and HLA-DR3
33. Erythrocyte thiolmethyltransferase: Another failed marker for Alzheimer's and Parkinson's diseases
34. Selective decrease in S-methylation in Parkinson's disease
35. Association of a monoamine oxidase B allele with Parkinson's disease